# Fortive

> Fortive owns specialist businesses that help industrial operators, facilities teams and healthcare providers measure equipment, protect workers, manage assets and run clinical workflows. Its ten operating brands combine instruments, software, consumables and services, supported by the Fortive Business System.

- **Founded:** 2016
- **Headquarters:** Everett, United States
- **Products:** Fluke, Advanced Sterilization Products, Censis, Fluke Health Solutions, Industrial Scientific
- **Notable:** Became independent from Danaher in July 2016., Completed the Ralliant spin-off on June 28, 2025, leaving two operating segments., Generated US$4.1591 billion in 2025 continuing-operations sales.

## Products & services

- **Fluke** — Professional test and measurement instruments, condition monitoring and maintenance software, including eMaint.
- **Advanced Sterilization Products** — Infection prevention systems, including STERRAD low-temperature sterilization, associated consumables and support.
- **Censis** — Surgical instrument tracking and sterile processing workflow software.
- **Fluke Health Solutions** — Biomedical testing and radiation safety through Fluke Biomedical, LANDAUER, RaySafe and related brands.
- **Industrial Scientific** — Gas detection equipment, connected safety monitoring and safety-as-a-service.
- **Intelex** — Environmental, health, safety and quality management applications.
- **Accruent** — Facilities and asset management software for the built environment.
- **Gordian** — Construction cost data, capital planning and Job Order Contracting solutions, including RSMeans Data.
- **Provation** — Procedure documentation and clinical workflow automation for healthcare providers.
- **ServiceChannel** — Facilities management SaaS, a service-provider network and managed services for multi-site businesses.

## Achievements

- Became independent from Danaher in July 2016.
- Completed the Ralliant spin-off on June 28, 2025, leaving two operating segments.
- Generated US$4.1591 billion in 2025 continuing-operations sales.
- Reported Q2 2026 core revenue growth of 6.7%, a non-GAAP measure excluding acquisition/divestiture and currency effects.
- ASP reports more than 22,000 STERRAD systems worldwide.

## Latest updates

- **2026-09** — Fortive scheduled its third-quarter 2026 earnings call for October 28, after this profile’s October 22 research cutoff.
- **2026-07** — Q2 2026 revenue reached US$1.0968 billion, up 7.9% reported and 6.7% core; adjusted full-year EPS guidance was raised to US$2.95-US$3.05.
- **2026-07** — Fortive reported roughly US$200 million of Q2 share repurchases, bringing the four-quarter total to roughly US$2 billion.
- **2025-09** — PENTAX Medical and ASP announced the U.S. launch of the Sterilizable DEC Duodenoscope.

## Links

- Website: https://fortive.com
- LinkedIn: https://www.linkedin.com/company/fortive/
- Twitter/X: https://x.com/FortiveCorp
- YouTube: https://www.youtube.com/channel/UCmnWkUlabmRqekE9mnjwY9g
- Facebook: https://facebook.com/fortivecorp/

---

Profile page: https://yespress.io/fortive
Published by YesPress — https://yespress.io
Last updated: 2026-10-22